RT Journal Article SR Electronic T1 Impaired sensory evidence accumulation and network function in Lewy body dementia JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.07.21249362 DO 10.1101/2021.01.07.21249362 A1 Claire O’Callaghan A1 Michael Firbank A1 Alessandro Tomassini A1 Julia Schumacher A1 John T O’Brien A1 John-Paul Taylor YR 2021 UL http://medrxiv.org/content/early/2021/01/11/2021.01.07.21249362.abstract AB Deficits in attention underpin many of the cognitive and neuropsychiatric features of Lewy body dementia. These attention-related symptoms remain difficult to treat and there are many gaps in our understanding of their neurobiology. An improved understanding of attention-related impairments can be achieved via mathematical modelling approaches, which identify cognitive parameters to provide an intermediate level between observed behavioural data and its underlying neural correlate. Here, we apply this approach to identify the role of impaired sensory evidence accumulation in the attention deficits that characterise Lewy body dementia. In 31 people with Lewy body dementia (including 13 Parkinson’s disease dementia and 18 dementia with Lewy bodies cases), 16 people with Alzheimer’s disease, and 23 healthy controls, we administered an attention task whilst they underwent functional 3T MRI. Using hierarchical Bayesian estimation of a drift diffusion model, we decomposed task performance into drift rate and decision boundary parameters. We tested the hypothesis that the drift rate – a measure of the quality of sensory evidence accumulation – is specifically impaired in Lewy body dementia, compared to Alzheimer’s disease. We further explored whether trial-by-trial variations in the drift rate related to activity within the default and dorsal attention networks, to determine whether altered activity in these networks was associated with slowed drift rates in Lewy body dementia. Our results revealed slower drift rates in the Lewy body dementia compared to the Alzheimer’s disease group, whereas the patient groups were equivalent for their decision boundaries. The patient groups were reduced relative to controls for both parameters. This highlights sensory evidence accumulation deficits as a key feature that distinguishes attention impairments in Lewy body dementia, consistent with impaired ability to efficiently process information from the environment to guide behaviour. We also found that the drift rate was strongly related to activity in the dorsal attention network across all three groups, whereas the Lewy body dementia group showed a divergent relationship relative to the Alzheimer’s disease and control groups for the default network, consistent with altered default network modulation being associated with impaired evidence accumulation. Together, our findings reveal impaired sensory evidence accumulation as a specific marker of attention problems in Lewy body dementia, which may relate to large-scale network abnormalities. By identifying impairments in a specific sub-process of attention, these findings will inform future exploratory and intervention studies that aim to understand and treat attention-related symptoms that are a key feature of Lewy body dementia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding CO was supported by a Neil Hamilton Fairley Fellowship from the Australian National Health and Medical Research Council (GNT1091310). AT was supported by a UK Medical Research Council Intramural Programme Grant (SUAG/051). JOB is supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Centre for Parkinson's Plus. The research was supported by a Wellcome Trust Intermediate Clinical Fellowship (WT088441MA) to J-PT, Northumberland Tyne and Wear NHS Foundation Trust, by National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, and by Alzheimer's Research UK. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NHS Health Research Authority: North East - Newcastle and North TynesideAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability Code and data to reproduce the manuscript figures, behavioural analysis and modelling for the Attention Network Task is freely available through the Open Science Framework (https://osf.io/gm8th/).